Optimization of short-term transgene expression by sodium butyrate and ubiquitous chromatin opening elements (UCOEs)

被引:14
作者
de Poorter, Jolanda J.
Lipinski, Kai S.
Nelissen, Rob G. H. H.
Huizinga, Tom W. J.
Hoeben, Rob C.
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Innovata PLC, Nottingham, England
关键词
gene therapy; adenovirus; sodium butyrate; CpG islands; UCOE;
D O I
10.1002/jgm.1057
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
Background Predictable and adequate transgene expression is essential for clinical gene therapy. Several studies have focused on optimization of transgene expression. In this study the effect of sodium butyrate (NaB) and a ubiquitous chromatin opening element (UCOE) on short-term gene expression after adenovirus-mediated gene transfer in fibroblastic interface cells from periprosthetic tissue in loosened orthopedic implants is investigated. Methods Cultures of diploid human interface cells from four patients were infected with an adenovirus type-5 vector that carries the luciferase gene driven by the cytomegalovirus (CMV) promoter as a reporter. In addition, viruses with a UCOE were evaluated. Twenty-four hours after infection NaB was added in concentrations of 0 to 9 mM Luciferase activity was tested after a further 24 h. Results NaB in a concentration of 6 mM caused a 7- to 16-fold increase in reporter gene expression compared to control condition. There was no difference in reporter gene expression when cells were infected with Ad.1.5UCOE-CMV.Luc compared to Ad.CMV.Luc. A combination of NaB and a UCOE had no advantage over NaB alone. Conclusions Addition of NaB results in a marked increase in transgene expression in cultured cells. This would allow the enhancement of the expression of the transgene, without requiring a higher vector dose. Butyrate administration could not be substituted by inclusion of UCOEs in the vector. It remains to be established whether the effective concentrations of butyrate can be obtained in vivo. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:639 / 648
页数:10
相关论文
共 32 条
[1]
Abdullah S, 2003, MOL THER, V7, pS73
[2]
Transgenes encompassing dual-promoter CpG islands from the human TBP and HNRPA2B1 loci are resistant to heterochromatin-mediated silencing [J].
Antoniou, M ;
Harland, L ;
Mustoe, T ;
Williams, S ;
Holdstock, J ;
Yague, E ;
Mulcahy, T ;
Griffiths, M ;
Edwards, S ;
Ioannou, PA ;
Mountain, A ;
Crombie, R .
GENOMICS, 2003, 82 (03) :269-279
[3]
The use of UCOE vectors in combination with a preadapted serum free, suspension cell line allows for rapid production of large quantities of protein [J].
Benton, T ;
Chen, T ;
McEntee, M ;
Fox, B ;
King, D ;
Crombie, R ;
Thomas, TC ;
Bebbington, C .
CYTOTECHNOLOGY, 2002, 38 (1-2) :43-46
[4]
Gene activation by histone and factor acetyltransferases [J].
Berger, SL .
CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) :336-341
[5]
Transcription factor Sp3 is regulated by acetylation [J].
Braun, H ;
Koop, R ;
Ertmer, A ;
Nacht, S ;
Suske, G .
NUCLEIC ACIDS RESEARCH, 2001, 29 (24) :4994-5000
[6]
Inhibition of histone deacetylase activity by butyrate [J].
Davie, JR .
JOURNAL OF NUTRITION, 2003, 133 (07) :2485S-2493S
[7]
Towards gene therapy in prosthesis loosening: efficient killing of interface cells by gene-directed enzyme prodrug therapy with nitroreductase and the prodrug CB1954 [J].
de Poorter, JJ ;
Toboom, TCA ;
Rabelink, MJWE ;
Pieterman, E ;
Hoeben, RC ;
Nelissen, RGHH ;
Huizinga, TWJ .
JOURNAL OF GENE MEDICINE, 2005, 7 (11) :1421-1428
[8]
Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase [J].
Dion, LD ;
Goldsmith, KT ;
Tang, DC ;
Engler, JA ;
Yoshida, M ;
Garver, RI .
VIROLOGY, 1997, 231 (02) :201-209
[9]
Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors [J].
Djeha, AH ;
Thomson, TA ;
Leung, H ;
Searle, PF ;
Young, LS ;
Kerr, DJ ;
Harris, PA ;
Mountain, A ;
Wrighton, CJ .
MOLECULAR THERAPY, 2001, 3 (02) :233-240
[10]
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses [J].
Fallaux, FJ ;
Bout, A ;
Van der Velde, I ;
Van den Wollenberg, DJM ;
Hehir, KM ;
Keegan, J ;
Auger, C ;
Cramer, SJ ;
Van Ormondt, H ;
Van der Eb, AJ ;
Valerio, D ;
Hoeben, RC .
HUMAN GENE THERAPY, 1998, 9 (13) :1909-1917